PIII — P3 Health Partners Cashflow Statement
0.000.00%
Last trade - 00:00- $197.60m
- $528.70m
- $1.27bn
- 32
- 71
- 20
- 36
Annual cashflow statement for P3 Health Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -42.9 | -45.4 | -204 | -1,562 | -186 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7.78 | -12.4 | 53.4 | 1,313 | -6.69 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.45 | 32.4 | 75.8 | 35.2 | 30.4 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -28.3 | -24.6 | -66.5 | -126 | -76 |
| Capital Expenditures | -1.45 | -2.93 | -3.41 | -2.23 | -1.83 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.4 | -0.24 | -52.7 | -5.5 | 0 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.86 | -3.17 | -56.1 | -7.73 | -1.83 |
| Financing Cash Flow Items | — | — | — | — | -0.364 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 63.6 | 34.8 | 223 | 11.4 | 100 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 31.5 | 7 | 101 | -122 | 22.5 |